Therapeptix ¿ Development of a Peptide-based Drug for the Treatment of Pseudomonas Biofilm Infection in Cystic Fibrosis

• Forschungsstelle: INNOSUISSE
• Projektnummer: 18366.1 PFLS-LS
• Projekttitel Englisch: Therapeptix ¿ Development of a Peptide-based Drug for the Treatment of Pseudomonas|Biofilm Infection in Cystic Fibrosis

Kurzbeschreibung (Deutsch)

Therapeptix ¿ Development of a Peptide-based Drug for the Treatment of Pseudomonas Biofilm Infection in Cystic Fibrosis

Kurzbeschreibung (Englisch)

Therapeptix ¿ Development of a Peptide-based Drug for the Treatment of Pseudomonas|Biofilm Infection in Cystic Fibrosis

Abstract (Deutsch)

This feasibility project presents a lead peptide with promising anti-biofilm properties, which we aim to develop|into a drug candidate for the treatment of Pseudomonas infection in cystic fibrosis (CF) patients. The novel|mechanism of action utilized by this drug would create a niche in the CF drug market. The intellectual property|(IP) arising from this project will serve as the basis for the establishment of a company and further|development to bring the drug to the market.

Abstract (Englisch)

This feasibility project presents a lead peptide with promising anti-biofilm properties, which we aim to develop|into a drug candidate for the treatment of Pseudomonas infection in cystic fibrosis (CF) patients. The novel|mechanism of action utilized by this drug would create a niche in the CF drug market. The intellectual property|(IP) arising from this project will serve as the basis for the establishment of a company and further|development to bring the drug to the market.